ResearcherKanazawa UniversityNo recent work listed
Shuichi Kaneko
Matched on ORCID iD 0000-0001-7113-3319; OpenAlex author ID A5069733713. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2020: 1 paper · 2021: 2 papers
Papers 3
- Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer. Last author DOI 10.1016/j.jcyt.2020.08.001↗
- Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors. Last author PMID 34249452↗
- Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. Co-author DOI 10.1038/s41388-020-01423-8↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taro Yamashita · 2 shared papers, 2021 · strength 0.22
- Paper Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognosti… PMID 34249452↗
- Paper Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic … DOI 10.1016/j.jcyt.2020.08.001↗
- Yoshio Sakai · 2 shared papers, 2021 · strength 0.22
- Paper Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognosti… PMID 34249452↗
- Paper Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic … DOI 10.1016/j.jcyt.2020.08.001↗
- Hiroki Matsukawa · 1 shared paper, 2021 · strength 0.11
- Isamu Makino · 1 shared paper, 2021 · strength 0.11
- Takeshi Terashima · 1 shared paper, 2021 · strength 0.11
- Takeharu Sakamoto · 1 shared paper, 2020 · strength 0.11
- Motoharu Seiki · 1 shared paper, 2020 · strength 0.11
- Akane Kanamori · 1 shared paper, 2020 · strength 0.11
- Tatsuo Kumai · 1 shared paper, 2021 · strength 0.11
- Shigenori Goto · 1 shared paper, 2021 · strength 0.11
- Tomoharu Miyashita · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.